|
|
|
|
||
Dough tweets on Ctmx catalysts - BAMLdough @tgtxdough · 3h $CTMX catalysts ASCO 2018 – CX-072 initial clinical readout CTMX • ESMO 2018 – CX-2009 initial clinical readout • 2018 – IND and clinical initiation of CX-188 (anti-PD-1) • 2018 – Initiation of clinical programs for partnered assets (ABBV & BMY 1 3 Show this thread dough dough @tgtxdough · 4h BAML $CTMX first-in-human data could be a significant 2018 catalyst First-in-human data for CTMX’s CX-072, anti-PD-L1 Probody, and CX-2009, anti-CD166 Probody-drug candidate, are anticipated at ASCO and ESMO |
return to message board, top of board |